Cancer program receives national award for outstanding achievement
Cancer stem cells are not ‘one size fits all’ lung cancer models show
Trends suggest increase in cancers of the lower stomach for younger whites in U.S.
Broccoli component limits breast cancer stem cells, study finds
Higher levels of vitamin B6, common amino acid associated with lower risk of lung cancer
|
Clinical Trials
Berkshire Hematology Oncology is committed to clinical trials, which are research studies that are conducted over a certain time period to answer important medical questions about the treatment and cure of diseases. Over the past three decades, BHO patients have participated in large-scale clinical trials that have led to groundbreaking discoveries in the fields of science and medicine. Currently, more than 400 BHO patients are participating in over 40 different national and international clinical trials. Through affiliations with national leading research groups-- including NSABP (National Surgical Adjuvant Breast and Bowel Project), ECOG (Eastern Cooperative Oncology Group), SWOG (Southwest Oncology Group), the National Cancer Institute and numerous pharmaceutical companies— the physicians of BHO are able to bring these important opportunities directly to our community, in the hope of benefiting our own patients as well as future patients worldwide. For more information about BHO's current clinical trials, call Gloria Gero, CCRA, at 413.496.8205, or email Gloria.Gero@berkshirehemonc.com |
LINKS
|